What is retatrutide, and can I get it?

Not available. Not approved. Not prescribable.

Retatrutide is investigational. It has not been approved by the FDA, it cannot be legally prescribed or sold in the United States, and we do not offer it. Approval is not expected before roughly 2027–2028. Anything sold online today as "retatrutide" is not a legitimate approved product. This page exists so you know what is real — and what is available to you right now instead.

In more than two decades of practicing medicine, I have learned that the fastest way to lose a year is to wait for the thing that is not here yet. Patients are already asking me about retatrutide, so let me tell you plainly what is real, what is not, and what you can actually do this month.

Why people are excited

Semaglutide works on one appetite hormone pathway. Tirzepatide works on two. Retatrutide, from Eli Lilly, works on three, adding a glucagon pathway that appears to increase how much energy the body burns. In trials, average weight loss came in around 28 percent of body weight over roughly a year and a half, with a large share of participants losing 30 percent or more — numbers that start to approach what weight-loss surgery achieves. Trials also showed benefits for liver fat, blood pressure, and sleep apnea.

MedicationHormone pathwaysAverage weight loss in trialsAvailable today?
SemaglutideOneAbout 15%Yes
TirzepatideTwoAbout 20–22%Yes
RetatrutideThreeAbout 28%No — investigational

The part I need you to take seriously

Retatrutide is still being studied. It cannot be legally prescribed or sold. That means any website, clinic, or compounding source advertising retatrutide right now is selling you something that is not an approved product, from a supply chain nobody is verifying, at a dose nobody has validated for you. That is not a shortcut. That is a real safety risk with an unknown substance. Researchers are also still characterizing its side effects, including a skin-sensitivity effect seen at the highest doses studied.

I will say this as directly as I can: we do not offer retatrutide, and if someone offers it to you, that is a reason to walk away from that provider entirely — not just from that drug.

What is available right now

Here is my stance as a physician. I follow this science closely, and when retatrutide is approved and its safety is established, we will be ready to offer it appropriately. Until then, chasing what is unavailable costs you the one thing you cannot get back, which is time. Semaglutide and tirzepatide are approved, extensively studied, and producing excellent results in my patients today — and the metabolic benefits of getting weight and blood sugar moving now compound every year you start earlier.

Measure, don’t guess

Whether a GLP-1 medication belongs in your plan at all depends on your labs, your history, your medications, and your goals. That is a consultation, not a checkout page. Related reading: semaglutide vs tirzepatide, GLP-1 benefits beyond weight loss, GLP-1 side effects, and can you reverse diabetes.

Retatrutide

Retatrutide, managed by your physician with a check-in every 30 days.

GLP-1 plans $349/month · first month $449

Questions first? Text us. Ready? Book now. · 1910 S Stapley Dr #120, Mesa, AZ 85204

To Health and Wellness,
Dr. Ty Tallman


This page covers general health information and is not a substitute for individual medical advice. Approval timelines and trial findings change; this page reflects the status as of its last update. Never obtain or use a prescription medication from an unapproved source.

Already a patient? A short review helps the next person find the care you found.

Review us on Google
Scroll to Top